Table 1.
Microvascular manifestations |
Renal (aPL nephropathy) |
Acute—thrombotic microangiopathy |
Chronic (ie, fibrous intimal hyperplasia, focal cortical atrophy, tubular thyroidization, glomerular ischemia, interstitial fibrosis, tubular atrophy, organized thrombi with or without recanalization) |
Pulmonary (diffuse alveolar hemorrhage) |
Cardiac (microvascular disease) |
Dermatologic (livedo with/without skin ulcers) |
Nonthrombotic manifestations |
Thrombocytopenia |
Immune mediated |
Thrombotic microangiopathy related |
Hemolytic anemia |
Immune mediated |
With schistocytes and thrombotic microangiopathy |
Cardiac valve vegetations or thickening |
Neurologic* |
Cognitive dysfunction in the absence of stroke |
Subcortical white matter changes |
Due to multiple mechanisms, including small vessel ischemic events and the direct pathogenic role of aPL.